Veterans affairs cooperative studies program study 553: Chemotherapy after prostatectomy, a phase III randomized study of prostatectomy versus prostatectomy with adjuvant docetaxel for patients with high-risk, localized prostate cancer

被引：13
|
作者：
Montgomery, Bruce [1 ]
Lavori, Philip
Garzotto, Mark
Lee, Kelvin
Brophy, Mary
Thaneemit-Chen, Surai
Kelly, William
Basler, Joseph
Ringer, Robert
Yu, Wei
Whittemore, Alice
Lin, Daniel W.
机构：
[1] Vet Affairs Puget Sound Hlth Care Syst, Div Med Oncol, Seattle, WA 98109 USA
来源：
UROLOGY | 2008年 / 72卷 / 03期
关键词：
D O I：
10.1016/j.urology.2008.02.050
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：474 / 480
页数：7
相关论文
共 50 条
  • [1] Veterans Affairs Cooperative Studies Program Study #553: Chemotherapy After Prostatectomy for High -risk Prostate Carcinoma: A Phase III Randomized Study
    Lin, Daniel W.
    Shih, Mei-Chiung
    Aronson, William
    Basler, Joseph
    Beer, Tomasz M.
    Brophy, Mary
    Cooperberg, Matthew
    Garzotto, Mark
    Kelly, W. Kevin
    Lee, Kelvin
    McGuire, Valerie
    Wang, Yajie
    Lu, Ying
    Markle, Vivian
    Nseyo, Unyime
    Ringer, Robert
    Savage, Stephen J.
    Sinnott, Patricia
    Uchio, Edward
    Yang, Claire C.
    Montgomery, R. Bruce
    EUROPEAN UROLOGY, 2020, 77 (05) : 563 - 572
  • [2] Adjuvant weekly docetaxel for high-risk prostate cancer patients after Radical Prostatectomy
    Kibel, AS
    Picus, J
    Cookson, MS
    Roth, B
    Jarrard, DF
    Wilding, G
    Klein, EA
    Dreicer, R
    Nelson, JB
    Chatta, G
    Benson, MC
    Petrylak, DP
    DiPaola, R
    Beer, TM
    Diamond, J
    Partin, AW
    Eisenberger, MA
    JOURNAL OF UROLOGY, 2005, 173 (04): : 222 - 222
  • [3] Adjuvant weekly docetaxel for high-risk prostate cancer patients after radical prostatectomy
    Kibel, AS
    Kattan, MW
    Picus, J
    Dreicer, R
    Klein, EA
    Wilding, G
    Jarrard, DF
    Roth, B
    Cookson, MS
    Pettylak, DP
    Chatta, G
    Nelson, JB
    Beer, TM
    Dipaola, R
    Partin, AI
    Rosenbaum, E
    Garrett, E
    Sugar, E
    Eisenberger, M
    JOURNAL OF UROLOGY, 2006, 175 (04): : 512 - 512
  • [4] Phase I study of weekly mitoxantrone and docetaxel before prostatectomy in patients with high-risk localized prostate cancer
    Beer, TM
    Garzotto, M
    Lowe, BA
    Ellis, WJ
    Montalto, MA
    Lange, PH
    Higano, CS
    CLINICAL CANCER RESEARCH, 2004, 10 (04) : 1306 - 1311
  • [5] VA CSP#553 CHEMOTHERAPY AFTER PROSTATECTOMY (CAP) FOR HIGH RISK PROSTATE CARCINOMA: A PHASE III RANDOMIZED STUDY
    Lin, Daniel
    Garzotto, Mark
    Aronson, William
    Basler, Joseph
    Beer, Thomas
    Brophy, Mary
    Kelly, Kevin
    Lee, Kelvin
    Lu, Ying
    Markle, Vivian
    McGuire, Valerie
    Nseyo, Unimye
    Ringer, Robert
    Savage, Steven
    Shih, Mei-Chiung
    Sinnott, Patricia
    Uchio, Edward
    Wang, Yajie
    Yang, Claire
    Montgomery, Bruce
    JOURNAL OF UROLOGY, 2016, 195 (04): : E1071 - E1071
  • [6] Neoadjuvant docetaxel before radical prostatectomy in patients with high-risk localized prostate cancer
    Febbo, PG
    Richie, JP
    George, DJ
    Loda, M
    Manola, J
    Shankar, S
    Barnes, AS
    Tempany, C
    Catalona, W
    Kantoff, PW
    Oh, WK
    CLINICAL CANCER RESEARCH, 2005, 11 (14) : 5233 - 5240
  • [7] Cancer and Leukemia Group B (CALGB) 90203: A randomized phase 3 study of radical prostatectomy alone versus estramustine and docetaxel before radical prostatectomy for patients with high-risk localized disease
    Eastham, JA
    Kelly, WK
    Grossfeld, GD
    Small, EJ
    UROLOGY, 2003, 62 (6B) : 55 - 62
  • [8] Adjuvant Therapy in High-Risk Prostate Cancer after Radical Prostatectomy A Randomized, open-label, Phase 2 Study of Adjuvant Apalutamide or Standard of Care in Subjects with High-risk, Localized or Locally Advanced Prostate Cancer After Radical Prostatectomy (ADAM) - Study AP 116/21 of AUO
    Rexer, Heidrun
    Boegemann, Martin
    Graefen, Markus
    AKTUELLE UROLOGIE, 2023, 54 (01) : 21 - 23
  • [9] Adjuvant chemotherapy and/or hormone therapy after radical prostatectomy for high-risk prostate cancer.
    Paule, B
    de la Taille, A
    PROGRES EN UROLOGIE, 2005, 15 (02): : 208 - 212
  • [10] Neoadjuvant docetaxel followed by radical prostatectomy in patients with high-risk localized prostate cancer: A preliminary report
    Oh, WK
    George, DJ
    Kaufman, DS
    Moss, K
    Smith, MR
    Richie, JP
    Kantoff, PW
    SEMINARS IN ONCOLOGY, 2001, 28 (04) : 40 - 44
12345